Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

Well said on using efficacy signals to predict trial failure, which is a head-scratcher. My bet is on easier population, less strict assessment scale and increased dosage will produce better results.

I also find it fascinating when those same doctors dismiss small trial data as too few and unreliable to use as evidence of any efficacy, yet use the same small data set to claim and project that there is a larger probability of little or no efficacy in the following trial.